Orange Book product · Brand (NDA)
FROVA
FROVATRIPTAN SUCCINATE
At a glance
Nov 08, 2001
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 08, 2001
25 yr ago
Today
Pharmaceutical detail
Active ingredient
FROVATRIPTAN SUCCINATE
Strength
EQ 2.5MG BASE
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
NDA 021006
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2025FROVATRIPTAN SUCCINATEGeneric (ANDA)
ANDA 216998 · LEADING
- 2022FROVATRIPTAN SUCCINATEGeneric (ANDA)
ANDA 213891 · RENATA
- 2018FROVATRIPTAN SUCCINATEGeneric (ANDA)
ANDA 211292 · AMNEAL PHARMS CO
- 2016FROVATRIPTAN SUCCINATEGeneric (ANDA)
ANDA 204730 · GLENMARK PHARMS LTD
- 2014FROVATRIPTAN SUCCINATEGeneric (ANDA)
ANDA 202931 · PHARMOBEDIENT
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
